Targeting the ROCK2-BACH1-CXCL5 axis alleviates sepsis-induced liver injury by restoring protective neutrophil recruitment

Sepsis-induced liver injury (SILI) is a fatal complication characterized by dysregulated immune responses. While early hepatic recruitment of neutrophils is critical for host defense and bacterial clearance, the molecular brakes that aberrantly restrict this protective mechanism during SILI remain poorly understood. Here, we identify Rho-associated coiled-coil-containing protein kinase 2 (ROCK2) as a pivotal upstream driver of SILI. ROCK2 is markedly upregulated in septic livers, and its genetic deficiency significantly improves survival, attenuates hepatic damage, and suppresses inflammation in septic mice. Furthermore, ROCK2 exacerbates SILI by impairing CXCL5-mediated hepatic neutrophil recruitment. Mechanistically, we uncovered a non-canonical mechanism wherein ROCK2 physically interacts with the transcription factor BACH1, competing with ubiquitin to prevent its proteasomal degradation. This aberrant stabilization enables BACH1 to directly occupy the CXCL5 promoter, silencing its transcription and dampening protective neutrophil infiltration. Overexpression of BACH1 or knockdown of CXCL5 abolished the hepatoprotective effects of ROCK2 deficiency. Moreover, we identified the natural compound epigallocatechin-3-gallate (EGCG) as a potent ROCK2 inhibitor. Pharmacological targeting of ROCK2 with EGCG effectively relieved BACH1-mediated repression, restored CXCL5 expression and neutrophil recruitment, and ameliorated SILI. Collectively, our findings delineate a novel ROCK2-BACH1-CXCL5-neutrophil pathogenic cascade, highlighting a unique kinase-mediated competitive stabilization of a transcription factor, and establish ROCK2 as an actionable therapeutic target for sepsis.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11545707/v1
Primary Topic
Sepsis Diagnosis and Treatment
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Targeting the ROCK2-BACH1-CXCL5 axis alleviates sepsis-induced liver injury by restoring protective neutrophil recruitment

Jipeng Liu, Jiarong Ye, Pengwei Lai, Leifeng Chen et al.
2 links
Research Square
Sepsis Diagnosis and Treatment
preprint

Targeting the ROCK2-BACH1-CXCL5 axis alleviates sepsis-induced liver injury by restoring protective neutrophil recruitment

Jipeng Liu, Jiarong Ye, Pengwei Lai, Leifeng Chen, Xu Zhang, Wen Zeng, Xingchi Zhou, Chaojie Zhai, haoran Qu, Zecheng Jiang, Du Xiaohong, Zuao Wang, Song Huang
preprint en

Abstract

Sepsis-induced liver injury (SILI) is a fatal complication characterized by dysregulated immune responses. While early hepatic recruitment of neutrophils is critical for host defense and bacterial clearance, the molecular brakes that aberrantly restrict this protective mechanism during SILI remain poorly understood. Here, we identify Rho-associated coiled-coil-containing protein kinase 2 (ROCK2) as a pivotal upstream driver of SILI. ROCK2 is markedly upregulated in septic livers, and its genetic deficiency significantly improves survival, attenuates hepatic damage, and suppresses inflammation in septic mice. Furthermore, ROCK2 exacerbates SILI by impairing CXCL5-mediated hepatic neutrophil recruitment. Mechanistically, we uncovered a non-canonical mechanism wherein ROCK2 physically interacts with the transcription factor BACH1, competing with ubiquitin to prevent its proteasomal degradation. This aberrant stabilization enables BACH1 to directly occupy the CXCL5 promoter, silencing its transcription and dampening protective neutrophil infiltration. Overexpression of BACH1 or knockdown of CXCL5 abolished the hepatoprotective effects of ROCK2 deficiency. Moreover, we identified the natural compound epigallocatechin-3-gallate (EGCG) as a potent ROCK2 inhibitor. Pharmacological targeting of ROCK2 with EGCG effectively relieved BACH1-mediated repression, restored CXCL5 expression and neutrophil recruitment, and ameliorated SILI. Collectively, our findings delineate a novel ROCK2-BACH1-CXCL5-neutrophil pathogenic cascade, highlighting a unique kinase-mediated competitive stabilization of a transcription factor, and establish ROCK2 as an actionable therapeutic target for sepsis.

Research Square
Second Affiliated Hospital of Nanchang University (CN)
National Natural Science Foundation of China, Jiangxi Provincial Department of Science and Technology
Good health and well-being
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon